The race to develop new obesity drugs is playing out with measures of how much and how quickly patients shed weight. Raj Kannan, CEO of startup Alveus Therapeutics, sees the field shaping up as a ...

For decades, drug safety has depended on one simple but demanding task: turning fragments of information from patients, physicians, and trials into clear signals that protect lives. Today, that ...

Novo Nordisk is expanding its reach in the obesity medicines market by making its blockbuster weight loss drug Wegovy available directly to certain patients for more than half off the product’s list ...

Freenome, developer of tests that identify early signs of cancer from a small sample of patient blood, is going public in a merger deal that will infuse the company with $330 million to support a ...

The next phase of AI in healthcare is about building systems where human clinicians, supervisors, and AI can all contribute, ...

Elevance Health is leveraging AI for simplifying the member experience, improving the provider experience and making sure ...

Healthcare affordability czar Casey Mulligan laid out the economic philosophy guiding the Trump administration's approach to ...

While the policy changes create new opportunities, they also introduce operational complexity. Here's some important things ...

The healthcare affordability crisis in the U.S. has quietly become a trust crisis, with a growing share of Americans walking ...

The true promise of AI lies not in autonomy of either the clinician or machine, but in a balanced collaboration that bolsters ...

Egg freezing has gained popularity as a fertility preservation tool, but experts say high costs, uncertain outcomes and ...

UniQure is preparing to seek accelerated FDA approval for its Huntington’s disease gene therapy, a move that follows the ...